Bridge­Bio, a biotech known for its mod­el of set­ting up sub­sidiaries to house its R&D pro­grams, is split­ting off its ...

No­vo Nordisk is still hit­ting a glass ceil­ing in rev­enues due to GLP-1 sup­ply con­straints even as sales keep ris­ing.

Jang-Ho Cha had no in­ter­est in leav­ing his post at No­var­tis, where he led trans­la­tion­al med­i­cine for the phar­ma ...

MPM BioIm­pact and No­vo Hold­ings are among a group of in­vestors pour­ing $103 mil­lion in­to a psy­che­del­ic biotech that ...

Novo Nordisk is still hitting a glass ceiling in revenues due to GLP-1 supply constraints even as sales keep rising. The ...

Sarep­ta Ther­a­peu­tics’ chief sci­en­tist sug­gest­ed that the FDA was ahead of sched­ule in re­view­ing the com­pa­ny’s ...

Chroma Medicine laid off an undisclosed number of employees earlier this week, as the privately held startup focuses its ...

CVS Health on Wednesday reported that it's been hit hard by higher medical costs. It led the company to slash its full-year ...

The Covid-era swag­ger is gone. The cost cuts are most­ly done. The ex­ec­u­tives are “cau­tious­ly op­ti­mistic.” And the ...

For biosimilars to win, AbbVie has to lose, according to Boehringer Ingelheim. The German drugmaker on Wednesday said that ...

Sen. Maggie Hassan (D-NH) is pressuring GSK to put a commonly used pediatric inhaler back on the market after the company stopped producing it in late 2023 in favor of an authorized generic version.

Senators questioned UnitedHealth Group CEO Andrew Witty for more than two hours on Tuesday over the February cyberattack that paralyzed the US healthcare industry for months and bled some providers ...